Cargando…

Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed

Ovarian cancer, one of the most common gynecological malignancies, is characterized by high mortality and poor prognosis. Cytoreductive surgery and chemotherapy remain the mainstay of ovarian cancer treatment, and most women experience recurrence after standard care therapies. There is compelling ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xiaoyi, Bian, Ce, Zhao, Xia, Yi, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582991/ https://www.ncbi.nlm.nih.gov/pubmed/36275669 http://dx.doi.org/10.3389/fimmu.2022.1034903

Ejemplares similares

Dendritic cell vaccine of gliomas: challenges from bench to bed
por: Zheng, Ye, et al.
Publicado: (2023)

Targeting 4-1BB for tumor immunotherapy from bench to bedside
por: Wang, Ya-Tao, et al.
Publicado: (2022)

PD-1/PD-L1 inhibitors for advanced or metastatic cervical cancer: From bench to bed
por: Huang, Weijia, et al.
Publicado: (2022)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

Externally-Controlled Systems for Immunotherapy: From Bench to Bedside
por: Tristán-Manzano, María, et al.
Publicado: (2020)

Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic
por: Rios-Hoyo, Alejandro, et al.
Publicado: (2023)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

Evaluation of immunotherapy efficacy in gynecologic cancer
por: Jiang, Genyi, et al.
Publicado: (2023)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
por: Lin, Yi, et al.
Publicado: (2022)

Exosomes: A potential tool for immunotherapy of ovarian cancer
por: Gong, Xiangjin, et al.
Publicado: (2023)

Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume I
por: Di, Xiang-jie, et al.
Publicado: (2023)

Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response
por: Chen, Jinjin, et al.
Publicado: (2022)

Rapid bench to bed in management of metastatic prostate cancer
por: Balaji, K. C.
Publicado: (2016)

Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside
por: Shamshiripour, Parisa, et al.
Publicado: (2022)

Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
por: Muccioli, Maria, et al.
Publicado: (2014)

Targeting DNA Repair Response Promotes Immunotherapy in Ovarian Cancer: Rationale and Clinical Application
por: Xie, Hongyu, et al.
Publicado: (2021)

Circular RNAs Involve in Immunity of Digestive Cancers From Bench to Bedside: A Review
por: Chen, Chunyue, et al.
Publicado: (2022)

From Bench to Bed: The Current Genome Editing Therapies for Glaucoma
por: He, Meihui, et al.
Publicado: (2022)

Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy
por: Rajtak, Alicja, et al.
Publicado: (2022)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Aspirin Intolerance: Experimental Models for Bed-to-Bench
por: Yamashita, Masamichi
Publicado: (2016)

COVID-19: From bench to bed side
por: Singh, Akriti, et al.
Publicado: (2020)

Light on osteoarthritic joint: from bench to bed
por: Zhou, Yingying, et al.
Publicado: (2022)

The role of cholesterol metabolism in tumor therapy, from bench to bed
por: Xia, Wenhao, et al.
Publicado: (2023)

Behavioral factors to modulate immunotherapy efficacy in cancer
por: Jongerius, C., et al.
Publicado: (2022)

Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2023)

Immunotherapy for Recurrent Glioma—From Bench to Bedside
por: Pu, Yi, et al.
Publicado: (2023)

Organoid Models for Cancer Research—From Bed to Bench Side and Back
por: Kastner, Carolin, et al.
Publicado: (2021)

Complete Androgen Insensitivity Syndrome: From Bench to Bed
por: Tyutyusheva, Nina, et al.
Publicado: (2021)

Intranasal COVID-19 vaccines: From bench to bed
por: Alu, Aqu, et al.
Publicado: (2022)

New Approaches to Diabetic Nephropathy from Bed to Bench
por: Tsai, Jun-Li, et al.
Publicado: (2022)

Immunotherapies catering to the unmet medical need of cold colorectal cancer
por: Yuan, Jun, et al.
Publicado: (2022)

Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer
por: Nersesian, Sarah, et al.
Publicado: (2019)

Targeted drug delivery system for ovarian cancer microenvironment: Improving the effects of immunotherapy
por: Peng, Hongling, et al.
Publicado: (2022)

The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection
por: Oster, Paul, et al.
Publicado: (2022)

Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms
por: Chandra, Janin, et al.
Publicado: (2022)

Advances in artificial intelligence to predict cancer immunotherapy efficacy
por: Xie, Jindong, et al.
Publicado: (2023)

Application of immune checkpoint inhibitors in EGFR-mutant non-small-cell lung cancer: from bed to bench
por: Jin, Rui, et al.
Publicado: (2020)

CXCR2: From Bench to Bedside
por: Stadtmann, Anika, et al.
Publicado: (2012)

From Bench to Bedside: Immunotherapy for Prostate Cancer
por: Tse, Brian Wan-Chi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tbr49i69cjluc0k5dr7q3ta0s2